Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Oncology Biosimilar market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Oncology Biosimilar market. Detailed analysis of key players, along with key growth strategies adopted by Oncology Biosimilar industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Baxter
F. Hoffmann-La Roche
Hospira
F Hoffmann-La Roche
Amgen
Allergan
BioXpress Therapeutics
Biocon
Sandoz
Mylan
Biogen
AbbVie
Dr. Reddy's Laboratories
Dr Reddy's Laboratories
Boehringer Ingelheim
By Type:
Protein
Hormones
Uucleic Acids
By End-User:
End-User 1
End-User 2
End-User 3
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Oncology Biosimilar Market
-
1.3 Market Segment by Type
1.3.1 Japan Oncology Biosimilar Market Size and Growth Rate of Protein from 2014 to 2026
1.3.2 Japan Oncology Biosimilar Market Size and Growth Rate of Hormones from 2014 to 2026
1.3.3 Japan Oncology Biosimilar Market Size and Growth Rate of Uucleic Acids from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Oncology Biosimilar Market Size and Growth Rate of Application 1 from 2014 to 2026
1.4.2 Japan Oncology Biosimilar Market Size and Growth Rate of Application 2 from 2014 to 2026
1.4.3 Japan Oncology Biosimilar Market Size and Growth Rate of Application 3 from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Oncology Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Oncology Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Oncology Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Oncology Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Oncology Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Oncology Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Oncology Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Oncology Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Oncology Biosimilar Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Oncology Biosimilar by Major Types
3.4.1 Market Size and Growth Rate of Protein
3.4.2 Market Size and Growth Rate of Hormones
3.4.3 Market Size and Growth Rate of Uucleic Acids
4 Segmentation of Oncology Biosimilar Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Oncology Biosimilar by Major End-Users
4.4.1 Market Size and Growth Rate of Oncology Biosimilar in Application 1
4.4.2 Market Size and Growth Rate of Oncology Biosimilar in Application 2
4.4.3 Market Size and Growth Rate of Oncology Biosimilar in Application 3
5 Market Analysis by Regions
-
5.1 Japan Oncology Biosimilar Production Analysis by Regions
-
5.2 Japan Oncology Biosimilar Consumption Analysis by Regions
6 Hokkaido Oncology Biosimilar Landscape Analysis
-
6.1 Hokkaido Oncology Biosimilar Landscape Analysis by Major Types
-
6.2 Hokkaido Oncology Biosimilar Landscape Analysis by Major End-Users
7 Tohoku Oncology Biosimilar Landscape Analysis
-
7.1 Tohoku Oncology Biosimilar Landscape Analysis by Major Types
-
7.2 Tohoku Oncology Biosimilar Landscape Analysis by Major End-Users
8 Kanto Oncology Biosimilar Landscape Analysis
-
8.1 Kanto Oncology Biosimilar Landscape Analysis by Major Types
-
8.2 Kanto Oncology Biosimilar Landscape Analysis by Major End-Users
9 Chubu Oncology Biosimilar Landscape Analysis
-
9.1 Chubu Oncology Biosimilar Landscape Analysis by Major Types
-
9.2 Chubu Oncology Biosimilar Landscape Analysis by Major End-Users
10 Kinki Oncology Biosimilar Landscape Analysis
-
10.1 Kinki Oncology Biosimilar Landscape Analysis by Major Types
-
10.2 Kinki Oncology Biosimilar Landscape Analysis by Major End-Users
11 Chugoku Oncology Biosimilar Landscape Analysis
-
11.1 Chugoku Oncology Biosimilar Landscape Analysis by Major Types
-
11.2 Chugoku Oncology Biosimilar Landscape Analysis by Major End-Users
12 Shikoku Oncology Biosimilar Landscape Analysis
-
12.1 Shikoku Oncology Biosimilar Landscape Analysis by Major Types
-
12.2 Shikoku Oncology Biosimilar Landscape Analysis by Major End-Users
13 Kyushu Oncology Biosimilar Landscape Analysis
-
13.1 Kyushu Oncology Biosimilar Landscape Analysis by Major Types
-
13.2 Kyushu Oncology Biosimilar Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Baxter
14.1.1 Baxter Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 F. Hoffmann-La Roche
14.2.1 F. Hoffmann-La Roche Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Hospira
14.3.1 Hospira Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 F Hoffmann-La Roche
14.4.1 F Hoffmann-La Roche Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Amgen
14.5.1 Amgen Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 Allergan
14.6.1 Allergan Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 BioXpress Therapeutics
14.7.1 BioXpress Therapeutics Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Biocon
14.8.1 Biocon Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Sandoz
14.9.1 Sandoz Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 Mylan
14.10.1 Mylan Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
14.11 Biogen
14.11.1 Biogen Company Profile and Recent Development
14.11.2 Market Performance
14.11.3 Product and Service Introduction
14.12 AbbVie
14.12.1 AbbVie Company Profile and Recent Development
14.12.2 Market Performance
14.12.3 Product and Service Introduction
14.13 Dr. Reddy's Laboratories
14.13.1 Dr. Reddy's Laboratories Company Profile and Recent Development
14.13.2 Market Performance
14.13.3 Product and Service Introduction
14.14 Dr Reddy's Laboratories
14.14.1 Dr Reddy's Laboratories Company Profile and Recent Development
14.14.2 Market Performance
14.14.3 Product and Service Introduction
14.15 Boehringer Ingelheim
14.15.1 Boehringer Ingelheim Company Profile and Recent Development
14.15.2 Market Performance
14.15.3 Product and Service Introduction
The List of Tables and Figures (Totals 82 Figures and 178 Tables)
Figure Japan Oncology Biosimilar Market Size and Growth Rate of Protein from 2014 to 2026
Figure Japan Oncology Biosimilar Market Size and Growth Rate of Hormones from 2014 to 2026
Figure Japan Oncology Biosimilar Market Size and Growth Rate of Uucleic Acids from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Oncology Biosimilar Market Size and Growth Rate of Application 1 from 2014 to 2026
Figure Japan Oncology Biosimilar Market Size and Growth Rate of Application 2 from 2014 to 2026
Figure Japan Oncology Biosimilar Market Size and Growth Rate of Application 3 from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Oncology Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Oncology Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Oncology Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Oncology Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Oncology Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Oncology Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Oncology Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Oncology Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Oncology Biosimilar Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Oncology Biosimilar
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Oncology Biosimilar by Different Types from 2014 to 2026
-
Table Consumption Share of Oncology Biosimilar by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Protein
Figure Market Size and Growth Rate of Hormones
Figure Market Size and Growth Rate of Uucleic Acids
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Oncology Biosimilar by Different End-Users from 2014 to 2026
-
Table Consumption Share of Oncology Biosimilar by Different End-Users from 2014 to 2026
Figure Japan Oncology Biosimilar Market Size and Growth Rate of Application 1 from 2014 to 2026
Figure Japan Oncology Biosimilar Market Size and Growth Rate of Application 2 from 2014 to 2026
Figure Japan Oncology Biosimilar Market Size and Growth Rate of Application 3 from 2014 to 2026
-
Table Japan Oncology Biosimilar Production by Regions
-
Table Japan Oncology Biosimilar Production Share by Regions
-
Figure Japan Oncology Biosimilar Production Share by Regions in 2014
-
Figure Japan Oncology Biosimilar Production Share by Regions in 2018
-
Figure Japan Oncology Biosimilar Production Share by Regions in 2026
-
Table Japan Oncology Biosimilar Consumption by Regions
-
Table Japan Oncology Biosimilar Consumption Share by Regions
-
Figure Japan Oncology Biosimilar Consumption Share by Regions in 2014
-
Figure Japan Oncology Biosimilar Consumption Share by Regions in 2018
-
Figure Japan Oncology Biosimilar Consumption Share by Regions in 2026
-
Table Hokkaido Oncology Biosimilar Consumption by Types from 2014 to 2026
-
Table Hokkaido Oncology Biosimilar Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Oncology Biosimilar Consumption Share by Types in 2014
-
Figure Hokkaido Oncology Biosimilar Consumption Share by Types in 2018
-
Figure Hokkaido Oncology Biosimilar Consumption Share by Types in 2026
-
Table Hokkaido Oncology Biosimilar Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Oncology Biosimilar Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Oncology Biosimilar Consumption Share by End-Users in 2014
-
Figure Hokkaido Oncology Biosimilar Consumption Share by End-Users in 2018
-
Figure Hokkaido Oncology Biosimilar Consumption Share by End-Users in 2026
-
Table Tohoku Oncology Biosimilar Consumption by Types from 2014 to 2026
-
Table Tohoku Oncology Biosimilar Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Oncology Biosimilar Consumption Share by Types in 2014
-
Figure Tohoku Oncology Biosimilar Consumption Share by Types in 2018
-
Figure Tohoku Oncology Biosimilar Consumption Share by Types in 2026
-
Table Tohoku Oncology Biosimilar Consumption by End-Users from 2014 to 2026
-
Table Tohoku Oncology Biosimilar Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Oncology Biosimilar Consumption Share by End-Users in 2014
-
Figure Tohoku Oncology Biosimilar Consumption Share by End-Users in 2018
-
Figure Tohoku Oncology Biosimilar Consumption Share by End-Users in 2026
-
Table Kanto Oncology Biosimilar Consumption by Types from 2014 to 2026
-
Table Kanto Oncology Biosimilar Consumption Share by Types from 2014 to 2026
-
Figure Kanto Oncology Biosimilar Consumption Share by Types in 2014
-
Figure Kanto Oncology Biosimilar Consumption Share by Types in 2018
-
Figure Kanto Oncology Biosimilar Consumption Share by Types in 2026
-
Table Kanto Oncology Biosimilar Consumption by End-Users from 2014 to 2026
-
Table Kanto Oncology Biosimilar Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Oncology Biosimilar Consumption Share by End-Users in 2014
-
Figure Kanto Oncology Biosimilar Consumption Share by End-Users in 2018
-
Figure Kanto Oncology Biosimilar Consumption Share by End-Users in 2026
-
Table Chubu Oncology Biosimilar Consumption by Types from 2014 to 2026
-
Table Chubu Oncology Biosimilar Consumption Share by Types from 2014 to 2026
-
Figure Chubu Oncology Biosimilar Consumption Share by Types in 2014
-
Figure Chubu Oncology Biosimilar Consumption Share by Types in 2018
-
Figure Chubu Oncology Biosimilar Consumption Share by Types in 2026
-
Table Chubu Oncology Biosimilar Consumption by End-Users from 2014 to 2026
-
Table Chubu Oncology Biosimilar Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Oncology Biosimilar Consumption Share by End-Users in 2014
-
Figure Chubu Oncology Biosimilar Consumption Share by End-Users in 2018
-
Figure Chubu Oncology Biosimilar Consumption Share by End-Users in 2026
-
Table Kinki Oncology Biosimilar Consumption by Types from 2014 to 2026
-
Table Kinki Oncology Biosimilar Consumption Share by Types from 2014 to 2026
-
Figure Kinki Oncology Biosimilar Consumption Share by Types in 2014
-
Figure Kinki Oncology Biosimilar Consumption Share by Types in 2018
-
Figure Kinki Oncology Biosimilar Consumption Share by Types in 2026
-
Table Kinki Oncology Biosimilar Consumption by End-Users from 2014 to 2026
-
Table Kinki Oncology Biosimilar Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Oncology Biosimilar Consumption Share by End-Users in 2014
-
Figure Kinki Oncology Biosimilar Consumption Share by End-Users in 2018
-
Figure Kinki Oncology Biosimilar Consumption Share by End-Users in 2026
-
Table Chugoku Oncology Biosimilar Consumption by Types from 2014 to 2026
-
Table Chugoku Oncology Biosimilar Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Oncology Biosimilar Consumption Share by Types in 2014
-
Figure Chugoku Oncology Biosimilar Consumption Share by Types in 2018
-
Figure Chugoku Oncology Biosimilar Consumption Share by Types in 2026
-
Table Chugoku Oncology Biosimilar Consumption by End-Users from 2014 to 2026
-
Table Chugoku Oncology Biosimilar Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Oncology Biosimilar Consumption Share by End-Users in 2014
-
Figure Chugoku Oncology Biosimilar Consumption Share by End-Users in 2018
-
Figure Chugoku Oncology Biosimilar Consumption Share by End-Users in 2026
-
Table Shikoku Oncology Biosimilar Consumption by Types from 2014 to 2026
-
Table Shikoku Oncology Biosimilar Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Oncology Biosimilar Consumption Share by Types in 2014
-
Figure Shikoku Oncology Biosimilar Consumption Share by Types in 2018
-
Figure Shikoku Oncology Biosimilar Consumption Share by Types in 2026
-
Table Shikoku Oncology Biosimilar Consumption by End-Users from 2014 to 2026
-
Table Shikoku Oncology Biosimilar Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Oncology Biosimilar Consumption Share by End-Users in 2014
-
Figure Shikoku Oncology Biosimilar Consumption Share by End-Users in 2018
-
Figure Shikoku Oncology Biosimilar Consumption Share by End-Users in 2026
-
Table Kyushu Oncology Biosimilar Consumption by Types from 2014 to 2026
-
Table Kyushu Oncology Biosimilar Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Oncology Biosimilar Consumption Share by Types in 2014
-
Figure Kyushu Oncology Biosimilar Consumption Share by Types in 2018
-
Figure Kyushu Oncology Biosimilar Consumption Share by Types in 2026
-
Table Kyushu Oncology Biosimilar Consumption by End-Users from 2014 to 2026
-
Table Kyushu Oncology Biosimilar Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Oncology Biosimilar Consumption Share by End-Users in 2014
-
Figure Kyushu Oncology Biosimilar Consumption Share by End-Users in 2018
-
Figure Kyushu Oncology Biosimilar Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Baxter
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter
Figure Sales and Growth Rate Analysis of Baxter
Figure Revenue and Market Share Analysis of Baxter
Table Product and Service Introduction of Baxter
Table Company Profile and Development Status of F. Hoffmann-La Roche
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann-La Roche
Figure Sales and Growth Rate Analysis of F. Hoffmann-La Roche
Figure Revenue and Market Share Analysis of F. Hoffmann-La Roche
Table Product and Service Introduction of F. Hoffmann-La Roche
Table Company Profile and Development Status of Hospira
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hospira
Figure Sales and Growth Rate Analysis of Hospira
Figure Revenue and Market Share Analysis of Hospira
Table Product and Service Introduction of Hospira
Table Company Profile and Development Status of F Hoffmann-La Roche
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche
Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche
Figure Revenue and Market Share Analysis of F Hoffmann-La Roche
Table Product and Service Introduction of F Hoffmann-La Roche
Table Company Profile and Development Status of Amgen
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
Figure Sales and Growth Rate Analysis of Amgen
Figure Revenue and Market Share Analysis of Amgen
Table Product and Service Introduction of Amgen
Table Company Profile and Development Status of Allergan
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan
Figure Sales and Growth Rate Analysis of Allergan
Figure Revenue and Market Share Analysis of Allergan
Table Product and Service Introduction of Allergan
Table Company Profile and Development Status of BioXpress Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioXpress Therapeutics
Figure Sales and Growth Rate Analysis of BioXpress Therapeutics
Figure Revenue and Market Share Analysis of BioXpress Therapeutics
Table Product and Service Introduction of BioXpress Therapeutics
Table Company Profile and Development Status of Biocon
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon
Figure Sales and Growth Rate Analysis of Biocon
Figure Revenue and Market Share Analysis of Biocon
Table Product and Service Introduction of Biocon
Table Company Profile and Development Status of Sandoz
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz
Figure Sales and Growth Rate Analysis of Sandoz
Figure Revenue and Market Share Analysis of Sandoz
Table Product and Service Introduction of Sandoz
Table Company Profile and Development Status of Mylan
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan
Figure Sales and Growth Rate Analysis of Mylan
Figure Revenue and Market Share Analysis of Mylan
Table Product and Service Introduction of Mylan
Table Company Profile and Development Status of Biogen
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen
Figure Sales and Growth Rate Analysis of Biogen
Figure Revenue and Market Share Analysis of Biogen
Table Product and Service Introduction of Biogen
Table Company Profile and Development Status of AbbVie
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
Figure Sales and Growth Rate Analysis of AbbVie
Figure Revenue and Market Share Analysis of AbbVie
Table Product and Service Introduction of AbbVie
Table Company Profile and Development Status of Dr. Reddy's Laboratories
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr. Reddy's Laboratories
Figure Sales and Growth Rate Analysis of Dr. Reddy's Laboratories
Figure Revenue and Market Share Analysis of Dr. Reddy's Laboratories
Table Product and Service Introduction of Dr. Reddy's Laboratories
Table Company Profile and Development Status of Dr Reddy's Laboratories
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr Reddy's Laboratories
Figure Sales and Growth Rate Analysis of Dr Reddy's Laboratories
Figure Revenue and Market Share Analysis of Dr Reddy's Laboratories
Table Product and Service Introduction of Dr Reddy's Laboratories
Table Company Profile and Development Status of Boehringer Ingelheim
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim
Figure Revenue and Market Share Analysis of Boehringer Ingelheim
Table Product and Service Introduction of Boehringer Ingelheim
-
